Serial Number | 87488370 |
Word Mark | GALT PHARMACEUTICALS |
Filing Date | Wednesday, June 14, 2017 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, May 1, 2019 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
Goods and Services | Pharmaceutical research and development services, including but not limited to, development and evaluation of products for the treatment of Meniere's disease, and development of pharmaceutical preparations and medicines derived from underused, undeveloped, discontinued, and/or previously marketed compounds |
Goods and Services | Pharmaceutical clinical services, namely, development of new treatment modalities in the nature of pharmaceutical treatment protocols derived from underused, undeveloped, discontinued and/or previously marketed compounds in unmet patient health needs |
Name/Portrait Description and/or Consent Statement | The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual. |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 20, 2017 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 20, 2017 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Galt Pharmaceuticals, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Atlanta, GA 30339 |
Event Date | Event Description |
Wednesday, May 1, 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Wednesday, May 1, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, October 3, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, October 3, 2018 | NON-FINAL ACTION E-MAILED |
Wednesday, October 3, 2018 | NON-FINAL ACTION WRITTEN |
Wednesday, September 12, 2018 | DIVISIONAL PROCESSING COMPLETE |
Thursday, September 6, 2018 | DIVISIONAL REQUEST RECEIVED |
Tuesday, September 11, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Thursday, September 6, 2018 | TEAS REQUEST TO DIVIDE RECEIVED |
Thursday, September 6, 2018 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Monday, August 20, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, August 20, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, August 14, 2018 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Friday, March 16, 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Friday, March 16, 2018 | FINAL REFUSAL E-MAILED |
Friday, March 16, 2018 | FINAL REFUSAL WRITTEN |
Tuesday, February 27, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, February 14, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 27, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 27, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, February 23, 2018 | ASSIGNED TO LIE |
Wednesday, February 14, 2018 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Tuesday, February 13, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, September 15, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, September 15, 2017 | NON-FINAL ACTION E-MAILED |
Friday, September 15, 2017 | NON-FINAL ACTION WRITTEN |
Thursday, September 14, 2017 | ASSIGNED TO EXAMINER |
Tuesday, June 20, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Saturday, June 17, 2017 | NEW APPLICATION ENTERED IN TRAM |